MOCKINGBIRD PHARMA

Serial Number 88438331
Registration 6076318
700

Registration Progress

Application Filed
May 20, 2019
Under Examination
Nov 12, 2019
Approved for Publication
Sep 17, 2019
Published for Opposition
Sep 17, 2019
Registered
Jun 9, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200609)
Due: Jun 09, 2026 154 days

Trademark Image

MOCKINGBIRD PHARMA

Basic Information

Serial Number
88438331
Registration Number
6076318
Filing Date
May 20, 2019
Registration Date
June 9, 2020
Published for Opposition
September 17, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 9, 2020
Registration
Registered
Classes
035

Rights Holder

Mockingbird Pharma LLC

16
Address
Suite 770
6060 North Central Expressway
Dallas, TX 75206

Ownership History

AWC Specialty RX Consulting LLC

Original Applicant
16
Dallas, TX

AWC Specialty RX Consulting LLC

Owner at Publication
16
Dallas, TX

Mockingbird Pharma LLC

New Owner After Publication #1
16
Dallas, TX

Mockingbird Pharma LLC

Original Registrant
16
Dallas, TX

USPTO Deadlines

Next Deadline
154 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200609)
Due Date
June 09, 2026
Grace Period Ends
December 09, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Jun 9, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 30, 2021 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Dec 30, 2021 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
Dec 29, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 29, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 29, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 29, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 29, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 9, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 8, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 7, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 17, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 31, 2020 IUAF S USE AMENDMENT FILED Loading...
Apr 17, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 31, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 18, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 12, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 17, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 17, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 28, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 15, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 6, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 6, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 6, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 6, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 6, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 5, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 23, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Wholesale drug distributorship services; wholesale distributorship services featuring prescription drugs and non-prescription over-the-counter (OTC) drugs
First Use Anywhere: Jan 1, 2020
First Use in Commerce: Jan 1, 2020

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"